BioSpace News Archive

AbCellera (Nasdaq: ABCL) today announced that Eli Lilly and Company (Lilly) has entered into a modified purchase agreement with the U.S. government to supply an additional 150,000 doses of bebtelovimab, the second antibody developed through AbCellera’s collaboration with Lilly, for approximately $275 million.

Critical Path Institute (C-Path) and Replica Analytics, an Aetion company, announced today a new partnership that involves leveraging synthetic data to further catalyze the generation of actionable solutions to accelerate drug development for rare diseases.

IAMA Therapeutics, a preclinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel medicines to make a difference in the lives of individuals suffering from brain disorders, announced today it will present a poster at the upcoming International Neuroscience Conference of the Federation of the European Neuroscience Societies (FENS).

The Foundation for Sarcoidosis Research (FSR) is proud to bring together sarcoidosis patients, caregivers, and family and friends at the Third Annual Global Virtual Patient Summit: Unveiling Possibilities.

A New Business Strategy report released by Data Bridge Market Research with the title Global Internet of Medical Things (IoMT) Market Study Forecast till 2028.

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) testing, today announced the publication of a manuscript in a leading journal in the organ transplant space, Transplantation, validating the performance of a novel two-threshold algorithm for its Prospera™ test for the assessment of transplant rejection.

Bolden Therapeutics, Inc. announced being awarded a Small Business Innovative Research grant for $497,500 from the National Institute on Aging of the National Institutes of Health.

Exicure, Inc. announced that, following the implementation of a one-for-thirty reverse stock split at 5:00 p.m. EDT today, the Company’s common stock will begin trading on a split-adjusted basis on Nasdaq effective with the open of business tomorrow, Thursday, June 30, 2022.

ANGLE plc, a world-leading liquid biopsy company, announces that at the Annual General Meeting of the Company held earlier, all resolutions were duly passed.

Regard (formerly known as HealthTensor), a software company developing an artificial intelligence (AI) co-pilot for physicians to help diagnose medical conditions, today announced it has raised $15.3 million in Series A funding.